BioSpace News Archive

Lone Star Bio

Caris’ Precision Oncology Alliance Welcomes University of Iowa Holden Comprehensive Cancer Center

Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that University of Iowa Holden Comprehensive Cancer Center has joined Caris’ Precision Oncology Alliance™ (POA).

November 16, 2022
·
4 min read
Genetown

ConcertAI’s TeraRecon Brings Neuro-oncology Imaging into the Eureka Clinical AI Platform with Imaging Biometrics Partnership

The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now provides clinicians with key quantitative insights and standardized metrics to make MR imaging analysis simple and fast with the addition of IB Clinic from Imaging Biometrics.

November 16, 2022
·
3 min read
Business

Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources

Myovant Sciences (NYSE: MYOV) today announced the appointment of Ann Tomlin as Senior Vice President of Human Resources.

November 16, 2022
·
3 min read
Business

MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval.

November 16, 2022
·
5 min read
Genetown

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - November 16, 2022

EyePoint Pharmaceuticals, Inc. announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2016 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635.

November 16, 2022
·
2 min read
Drug Development

Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial

Monopar Therapeutics Inc. today released encouraging data from its ongoing Phase 1b open-label clinical trial of camsirubicin in advanced soft tissue sarcoma patients.

November 16, 2022
·
6 min read
Biotech Beach

NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference

NuVasive, Inc. announced today that Chief Executive Officer Chris Barry will participate in the Piper Sandler 34th Annual Healthcare Conference in New York on Wednesday, November 30, 2022.

November 16, 2022
·
2 min read
Drug Development

Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print

BIOXYTRAN, INC. announced positive topline safety and efficacy results of its randomized, placebo-controlled Phase 2 clinical trial in 34 patients with mild-to-moderate COVID-19.

November 16, 2022
·
6 min read
Genetown

SeQure Dx Emerges From Stealth Mode to Fulfill the Promise of On-Target Gene Editing Therapies for Biopharma Partners, Physicians, and Patients

SeQure Dx has announced its emergence from stealth mode with an aim to partner with biopharma companies developing gene editing therapeutics.

November 16, 2022
·
5 min read
Alvotech Secures Financing Facilities of Approximately $136 Million

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced financing facilities securing gross proceeds of approximately $136 million, at current exchange rates.

November 16, 2022
·
9 min read